Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Baxter
Harvard Business School
Medtronic
Daiichi Sankyo
US Army
Queensland Health
Cipla
McKesson

Generated: June 18, 2018

DrugPatentWatch Database Preview

EXELDERM Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Exelderm, and what generic alternatives are available?

Exelderm is a drug marketed by Sun Pharm Inds Inc and is included in two NDAs.

The generic ingredient in EXELDERM is sulconazole nitrate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the sulconazole nitrate profile page.
Summary for EXELDERM
US Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: 1
Bulk Api Vendors: 81
Patent Applications: 2,716
DailyMed Link:EXELDERM at DailyMed
Drug patent expirations by year for EXELDERM
Pharmacology for EXELDERM
Ingredient-typeAzoles
Drug ClassAzole Antifungal
Synonyms for EXELDERM
(+-)-1-(2,4-Dichloro-beta-((4-chlorobenzyl)thio)phenethyl)imidazole nitrate
(+-)-1-(2,4-Dichloro-beta-((p-chlorobenzyl)thio)phenethyl)imidazole mononitrate
1-(2-((4-Chlorobenzyl)thio)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole nitrate
1-(2-[p-Chlorobenzylthio]-2-[2,4-dichlorophenyl]ethyl)-1H-imidazole
1-(2-{[(4-chlorophenyl)methyl]sulfanyl}-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole; nitric acid
1-[2-(4-Chlorobenzylthio)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole nitrate
1-[2-[(4-chlorophenyl)methylsulfanyl]-2-(2,4-dichlorophenyl)ethyl]imidazole; nitric acid
1-[2-[(4-chlorophenyl)methylsulfanyl]-2-(2,4-dichlorophenyl)ethyl]imidazole;nitric acid
1-[2-[(4-chlorophenyl)methylthio]-2-(2,4-dichlorophenyl)ethyl]imidazole; nitric acid
1H-Imidazole, 1-(2-(((4-chlorophenyl)methyl)thio)-2-(2,4-dichlorophenyl)ethyl)-, mononitrate, (+-)-
1H-Imidazole, 1-(2-(((4-chlorophenyl)methyl)thio)-2-(2,4-dichlorophenyl)ethyl)-,mononitrate, (+-)-
1H-Imidazole, 1-[2-[[(4-chlorophenyl)methyl]thio]-
3B1-008259
61318-91-0
61318-91-0(nitrate)
82382-23-8
A833159
AB0014236
AC-26451
AC1L23CV
AC1Q21VV
AK117764
AKOS015897482
API0007242
C-46111
C18H15Cl3N2S.HNO3
C18H16Cl3N3O3S
CAS-61318-91-0
CCG-39015
CHEBI:9326
CHEMBL1200348
CS-5890
CTK3E7993
D00886
DSSTox_CID_25490
DSSTox_GSID_45490
DSSTox_RID_80911
DTXSID2045490
Exelderm (TN)
FT-0659334
HE009983
HE392540
HMS1570B21
HMS1921L03
HMS2092H09
HMS2097B21
HMS2232B18
HMS3370H17
HMS3652C18
HMS500K22
HY-B1460A
I09-1256
I14-14346
J10283
K466
KB-216959
KM2116
KS-00000XMU
KS-00001FBW
KS-1471
LS-78325
MFCD00058163
MLS000028611
MLS001146948
MLS002222171
MolPort-003-666-367
NCGC00016898-01
NCGC00018250-06
NCGC00094911-01
NCGC00094911-02
NCGC00094911-03
NCGC00094911-04
NITRIC ACID; SULCONAZOLE
NSC-757849
NSC757849
Opera_ID_1591
Pharmakon1600-01501148
Prestwick_128
RS 44872
RS-44872
RS-44872-00-10-3
RS-44872-00-1O-3
s4120
SC-16173
SC-94845
SCHEMBL36906
SMR000058734
SPECTRUM1501148
SR-01000000237
SR-01000000237-2
ST24037038
ST51053640
sulconazle nitrate
Sulconazole (nitrate)
Sulconazole mononitrate
Sulconazole nitrate
Sulconazole nitrate (JAN/USP)
Sulconazole nitrate [USAN:JAN]
Sulconazole nitrate [USAN:USP:JAN]
Sulconazole nitrate salt
sulconazole, mononitrate, (+-)-isomer
Sulconazole(nitrate)
Sulconazolenitrate
Tox21_110671
Tox21_110671_1

US Patents and Regulatory Information for EXELDERM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Inc EXELDERM sulconazole nitrate CREAM;TOPICAL 018737-001 Feb 28, 1989 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharm Inds Inc EXELDERM sulconazole nitrate SOLUTION;TOPICAL 018738-001 Aug 30, 1985 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Covington
Boehringer Ingelheim
QuintilesIMS
Argus Health
Colorcon
Harvard Business School
Fish and Richardson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.